Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 4Unknown 1Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1

Interventions

Cyclophosphamide 20Rituximab 18obinutuzumab 14Lenalidomide 14zanubrutinib 11fludarabine 10Bendamustine Hydrochloride 10Prednisone 8Magnetic Resonance Spectroscopy 8Vincristine 7Doxorubicin 7Specimen Handling 6fludarabine phosphate 5Radiotherapy 4Biopsy 4axicabtagene ciloleucel 3Whole-Body Irradiation 3tisagenlecleucel 2polatuzumab vedotin 2pirtobrutinib 2loncastuximab tesirine 2Therapeutics 2Prednisolone 2Positron Emission Tomography Computed Tomography 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Leukapheresis 2Immunotherapy, Adoptive 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Lymphoma, Follicular × R-CHOP protocol × Clear all
NCT06549595 2026-05-20

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

AstraZeneca

Phase 3 Recruiting
1,018 enrolled
Lymphoid

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡